Compare · head to head
Australian Clinical Labs vs Nihon Kohden
Nihon Kohden ranks higher overall — 360 rank 82 vs 65.
Nihon Kohden leads on Value (76 vs 68), Growth (48 vs 26) and Safety (65 vs 45). Australian Clinical Labs leads on Quality (78 vs 58) and Sentiment (48 vs 38).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Australia | Japan |
| Sector | Health Care | Health Care |
| Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| Size | Medium | Large |
| ISIN | AU0000148496 | JP3706800004 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 65 | 82 |
| Value | 68 | 76 |
| Quality | 78 | 58 |
| Growth | 26 | 48 |
| Safety | 45 | 65 |
| Sentiment | 48 | 38 |
| Quality details | ||
| Profitability | 75 | 70 |
| Cash Truth | 80 | 46 |
Australian Clinical Labs vs HealiusAustralian Clinical Labs vs Prenetics GlobalAustralian Clinical Labs vs Apex BiotechnologyAustralian Clinical Labs vs SonicAdd a third stock →
Full analyses: Australian Clinical Labs · Nihon Kohden
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100